Inspire Medical Systems Analyst Price Targets

Wall Street analyst price targets and consensus rating for Inspire Medical Systems (INSP).

Price Target Range — 9 Quarters

Analyst Consensus — 16 Analysts

6Buy

8Hold

2Sell

Consensus RatingNeutral# Analysts16Avg. Consensus PT$85Upside to Avg. PT+19.7%

Rating Trend — Last 9 Months

Recent Analyst Actions

Ver todas las valoraciones →

Date	Firm	Analyst	Action	Rating Change	Price Target
Oct 14, 2026	Truist Securities	Richard Newitter	PT Raise	Hold	$62→$78
Oct 7, 2026	Barclays	Christopher Pasquale	Initiate	Underweight	$65
Oct 2, 2026	Freedom Capital Markets	Keith Hinton	Maintained	Buy	$97
Oct 1, 2026	RBC Capital	Kendall Au	PT Raise	Sector Perform	$60→$75
Sep 21, 2026	Freedom Capital Markets	Keith Hinton	PT Raise	Buy	$71→$97
Sep 11, 2026	Stifel	Jonathan Block	PT Raise	Buy	$75→$80
Aug 4, 2026	JP Morgan	Robbie Marcus	PT Raise	Neutral	$54→$60
Aug 4, 2026	Mizuho	Anthony Petrone	PT Raise	Outperform	$55→$65
Aug 4, 2026	Oppenheimer	Suraj Kalia	Upgrade	Perform→Outperform	$85
Aug 4, 2026	Truist Securities	Richard Newitter	PT Raise	Hold	$54→$62
Aug 4, 2026	Piper Sandler	Adam Maeder	PT Raise	Neutral	$55→$60
Aug 4, 2026	Evercore ISI Group	Daniel Markowitz	PT Raise	In-Line	$40→$54
Aug 4, 2026	Baird	Mike Polark	PT Raise	Neutral	$54→$59
Jul 28, 2026	UBS	Patrick Wood	Assumes	Neutral→Sell	$67→$39
Jul 16, 2026	Truist Securities	Richard Newitter	PT Raise	Hold	$50→$54
Jul 1, 2026	Freedom Capital Markets	Keith Hinton	Initiate	Buy	$62
Jun 23, 2026	Evercore ISI Group	Daniel Markowitz	Downgrade	Outperform→In-Line	$55→$40
May 7, 2026	Oppenheimer	Suraj Kalia	Maintained	Perform	—
May 5, 2026	JP Morgan	Robbie Marcus	PT Cut	Neutral	$67→$54
May 5, 2026	Piper Sandler	Adam Maeder	Downgrade	Overweight→Neutral	$85→$55

Analyst Ratings News

PRO
Truist Securities Maintains Hold on Inspire Medical Systems, Raises Price Target to $78

Truist Securities analyst Richard Newitter maintains Inspire Medical Systems (NYSE:INSP) with a Hold and raises the price target from $62 to $78.

Benzinga Newsdesk

PRO
Barclays Initiates Coverage On Inspire Medical Systems with Underweight Rating, Announces Price Target of $65

Barclays analyst Christopher Pasquale initiates coverage on Inspire Medical Systems (NYSE:INSP) with a Underweight rating and announces Price Target of $65.

Benzinga Newsdesk

PRO
RBC Capital Maintains Sector Perform on Inspire Medical Systems, Raises Price Target to $75

RBC Capital analyst Kendall Au maintains Inspire Medical Systems (NYSE:INSP) with a Sector Perform and raises the price target from $60 to $75.

Benzinga Newsdesk

PRO
Freedom Capital Markets Maintains Buy on Inspire Medical Systems, Raises Price Target to $97

Freedom Capital Markets analyst Keith Hinton maintains Inspire Medical Systems (NYSE:INSP) with a Buy and raises the price target from $71 to $97.

Benzinga Newsdesk

PRO
Stifel Maintains Buy on Inspire Medical Systems, Raises Price Target to $80

Stifel analyst Jonathan Block maintains Inspire Medical Systems (NYSE:INSP) with a Buy and raises the price target from $75 to $80.

Benzinga Newsdesk

PRO
JP Morgan Maintains Neutral on Inspire Medical Systems, Raises Price Target to $60

JP Morgan analyst Robbie Marcus maintains Inspire Medical Systems (NYSE:INSP) with a Neutral and raises the price target from $54 to $60.

Benzinga Newsdesk

Inspire Medical Systems Inc

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL

Inspire Medical Systems Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PRO
Truist Securities Maintains Hold on Inspire Medical Systems, Raises Price Target to $78

PRO
Barclays Initiates Coverage On Inspire Medical Systems with Underweight Rating, Announces Price Target of $65

PRO
RBC Capital Maintains Sector Perform on Inspire Medical Systems, Raises Price Target to $75

PRO
Freedom Capital Markets Maintains Buy on Inspire Medical Systems, Raises Price Target to $97

PRO
Stifel Maintains Buy on Inspire Medical Systems, Raises Price Target to $80

PRO
JP Morgan Maintains Neutral on Inspire Medical Systems, Raises Price Target to $60

People Also Watch

People Also Watch

Inspire Medical Systems Inc

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL

Inspire Medical Systems Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PROTruist Securities Maintains Hold on Inspire Medical Systems, Raises Price Target to $78

PROBarclays Initiates Coverage On Inspire Medical Systems with Underweight Rating, Announces Price Target of $65

PRORBC Capital Maintains Sector Perform on Inspire Medical Systems, Raises Price Target to $75

PROFreedom Capital Markets Maintains Buy on Inspire Medical Systems, Raises Price Target to $97

PROStifel Maintains Buy on Inspire Medical Systems, Raises Price Target to $80

PROJP Morgan Maintains Neutral on Inspire Medical Systems, Raises Price Target to $60

People Also Watch

People Also Watch

PRO
Truist Securities Maintains Hold on Inspire Medical Systems, Raises Price Target to $78

PRO
Barclays Initiates Coverage On Inspire Medical Systems with Underweight Rating, Announces Price Target of $65

PRO
RBC Capital Maintains Sector Perform on Inspire Medical Systems, Raises Price Target to $75

PRO
Freedom Capital Markets Maintains Buy on Inspire Medical Systems, Raises Price Target to $97

PRO
Stifel Maintains Buy on Inspire Medical Systems, Raises Price Target to $80

PRO
JP Morgan Maintains Neutral on Inspire Medical Systems, Raises Price Target to $60